Pfizer STN 37.5 mg (Sutent 37.5 mg)
Generic Name: sunitinib
Pill imprint Pfizer STN 37.5 mg has been identified as Sutent 37.5 mg.
Sutent is used in the treatment of renal cell carcinoma; gastrointestinal stromal tumor; pancreatic cancer and belongs to the drug classes multikinase inhibitors, VEGF/VEGFR inhibitors. There is positive evidence of human fetal risk during pregnancy. Sutent 37.5 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- Pfizer STN 37.5 mg
- 37.5 mg
- Prescription only
- Drug Class:
- Multikinase inhibitors
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- Not a controlled drug
- Pfizer U.S. Pharmaceuticals Group
More about Sutent (sunitinib)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.